Skip to main content
. Author manuscript; available in PMC: 2021 Aug 20.
Published in final edited form as: Clin Genitourin Cancer. 2021 Mar 16;19(4):362–368. doi: 10.1016/j.clgc.2021.03.007

Figure 2.

Figure 2.

Kaplan-Meier survival estimates for patients treated with trimodality therapy (TMT) with or without neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer, with overall survival defined from start date of radiation.